FDA Approves Third-Ever Drug for Lupus Nephritis – Medscape

1. FDA Approves Third-Ever Drug for Lupus Nephritis  Medscape
2. Roche Receives FDA Approval for Kidney Inflammation Drug  The Wall Street Journal
3. Lupus Research Alliance Applauds U.S. FDA Approval of Gazyva® (Obinutuzumab) for Lupus Nephritis  Morningstar
4. Roche says FDA approves Gazyva/Gazyvaro for the treatment of lupus nephritis  MarketScreener
5. Roche’s Gazyva Expands Out of Cancer With FDA Approval for Lupus  BioSpace

Continue Reading